Few topics these days are blazing as brightly as the issue of medical marijuana. In April 2016, Pennsylvania became the 24th state to legalize the use of marijuana for medicinal purposes. Used to treat an enumerated list of “serious medical conditions” including epilepsy, multiple sclerosis and cancer, Pennsylvania lawmakers have emphasized the scientific research supporting the improvements made in patients suffering extreme and debilitating symptoms.
Aside from the documented health benefits, and after the state of Colorado raked in a total of $8.76 million in medical marijuana tax revenue in a single year ($200 million total when including tax revenue from the state’s reported $1 billion in recreational marijuana sales), it is easy to see the appeal of Pennsylvania’s relatively new medical marijuana legislation, known as “Act 16 of 2016.” This past Tuesday, June 20, Pennsylvania state Sen. Daylin Leach announced the award of permits to 12 applicants permitting the cultivation and processing of medical marijuana as “a huge day for patients and for the people of Pennsylvania.” After six months, so long as the growers can demonstrate that their facilities are operational, they may proceed to grow medical marijuana. Yes, Pennsylvanians, legalized pot is (finally) here.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
